SMSamer Shukur Mohammed

Samer Shukur Mohammed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samer Shukur Mohammed has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pharmacovigilance awareness and adverse events reaction reporting practices among pharmacy students in Iraq: A cross-sectional study

    by Samer Shukur Mohammed

    Introduction: Pharmacovigilance (PV) plays an important role in ensuring the safety of medicines through detecting, assessing, and preventing adverse drug reactions (ADR) associated with medicine use. Despite the importance of ADR, several studies showed limited awareness and underreporting of ADRs among healthcare students, particularly in developing countries. Aim: This study aimed to assess the knowledge, attitudes and practices (KAP) of Iraqi pharmacy students regarding PV and ADR reporting, Identify the barriers influencing their reporting and examine differences in KAP by academic level (final year vs 1–4 year). Methods: A cross-sectional survey was conducted among 412 pharmacy students from various private and government universities and colleges in Iraq. A structured, validated questionnaire was employed to assess the participant’s demographics, KAP and barriers to ADR reporting. Data were analysed using SPSS, with chi-square tests used to determine associations; p < 0.05 was considered to indicate significance. Results: Most participants (60.4%) had never heard of PV, and 55.8% rated their knowledge as poor. Only 29.8% had reported an ADR, and 70.1% had never done so; insufficient knowledge of reporting procedures was the most frequently cited barrier (56.3%). Attitudes were more positive, with 74% acknowledging the importance of ADR reporting. Gender was not significantly associated with KAP ( p > 0.05). Final year students showed significant improvement in their knowledge and attitudes ( p < 0.05). Conclusion: Pharmacy students in Iraq demonstrated limited knowledge and practice regarding PV. However, they exhibited positive attitudes toward it. These findings underscore the urgent need to integrate PV education into pharmacy curricula, strengthen practical training and foster collaboration with regulatory authorities to enhance ADR reporting before graduation.

  • Open Access

    The Impact of Exam-Related Anxiety on Irritable Bowel Syndrome Prevalence in Pharmacy Students

    by Samer Shukur Mohammed, Maha Ali Saleh, Rawnaq Jamal Alkhafaji, Ishraq Khadim Abbas

    To study the prevalence, subtypes, and risk factors of irritable bowel syndrome (IBS) among pharmacy students in Baghdad, Iraq, and to evaluate the correlation between exam-related stress and IBS incidence. A cross-sectional study was conducted with 650 randomly selected pharmacy students, aged 19 to 23 years, from several pharmacy colleges in Baghdad, between September 2024 and January 2025. Data were collected using an anonymous questionnaire addressing demographics, lifestyle characteristics, familial history, Rome IV diagnostic criteria for IBS, and anxiety in response to academic pressure. Statistical analysis was conducted using the IBM SPSS Statistics software and the Chi-squared test. From the total (n = 650), IBS was diagnosed in 64%, with a markedly higher frequency in females (80%) than in males (20%). The most prevalent subtype was unclassified (53.8%), followed by diarrhea (IBS-D: 13%) predominance, and constipation predominance (IBS-C: 9%). Family history of IBS (p = 0.0001) and diminished sleep duration (< 8 hours) were strongly correlated with IBS, although food hypersensitivity and chronic medication usage were not. Exam-related anxiety, particularly during final examinations, was significantly correlated with an increased frequency of IBS (p = 0.000). Irritable bowel syndrome (IBS) is widespread among pharmacy students in Baghdad, especially among females and individuals with a familial predisposition. Stress produced by examinations and insufficient sleep were significant exacerbating factors.

  • The importance of nutrivigilance in Middle East countries and the necessity for incorporation into pharmacovigilance health authorities’ regulations

    by Samer Shukur Mohammed

    Background: Nutrivigilance has become increasingly vital as global supplement consumption rises. However, in many Middle Eastern countries, these products are marketed with limited oversight and minimal integration within existing pharmacovigilance systems. Objective: To highlight the public health importance of nutrivigilance, review international models, and propose the incorporation of nutrivigilance practices into pharmacovigilance regulations within Middle Eastern health authorities. Methods: This perspective synthesizes findings from global regulatory frameworks, including the U.S. FDA, European Food Safety Authority (EFSA), and national nutrivigilance programs and evaluates their applicability in Middle Eastern contexts. Results: Significant variability exists between countries regarding nutrivigilance implementation. Developed nations employ structured post-marketing surveillance systems, whereas Middle Eastern countries lack harmonized approaches. The absence of specialized nutrivigilance units and public awareness campaigns contributes to underreporting and potential adverse health outcomes. Integrating nutrivigilance into national pharmacovigilance programs could enhance consumer safety, regulatory decision-making, and data sharing. Conclusion: Establishing nutrivigilance within Middle Eastern pharmacovigilance regulations is an urgent public health priority. Creating dedicated departments, harmonizing standards, fostering regional collaboration, and enhancing reporting culture will strengthen safety monitoring and consumer protection.

  • Open Access

    Bacterial Community Diversity, Richness, and Possible Immunotherapies Association in Response to Spray-Dried Porcine Plasma-Fed Diet: An Animal Model

    by Pirmatova Alina, Imad Ghanem Qasim, Sura Akram Mohammed, Samer Shukur Mohammed, Waleed Nassar, Nazarzoda Khusin Nazir

    This study aims to demonstrate the significance of employing non-invasive dietary intervention to control the diversity and abundance of bacterial communities in feces. The indexing databases Scopus, PubMed/Medline, ISI Web of Science, Embase, Cochrane Central, and CINAHL were extensively searched. Only 13 of 541 papers found in the initial searches met the criteria. Seven studies involving 210 animals were included in this meta-analysis. The SDPP group showed statistically lower Shannon (SMD: 1.20, 95% CI: 0.22–2.19, I2: 88%, p = 0.02) and Chao1 (SMD: 2.95, 95% CI: 1.99–3.91, I2: 77%, p < 0.00001) indices than the control group. The SDPP-diet fed group showed notably lower OTU counts compared to the control group (SMD: 2.99, 95% CI: 0.67–5.32, I2: 97%, p = 0.01). The Firmicutes/Bacteroidetes ratio is reliably increased following the SDPP-fed diet (SMD: 0.68, 95% CI: 0.13–1.23, I2: 0%, p = 0.02). While noticeable differences existed between studies and difficulties were encountered in replicating basic ecological measurements, the purpose of this analysis was to identify the consistent characteristics of the gut microbiota's response to the SDPP diet, thereby pinpointing specific areas for further mechanistic research.

  • Open Access

    Immunotherapy in Patients With Allergic Asthma and Chronic Allergic Rhinitis: A Retrospective Cohort

    by Seitova Aziza, Ahmed Mahdi Jassim, Sura Akram Mohammed, Samer Shukur Mohammed, Waleed Nassar, Mohd Faizan Siddiqui

    Asthma and allergies both cause similar signs and symptoms and often occur together. Evidence for the effectiveness of immunotherapy has rapidly increased in recent years. Several well-designed studies have demonstrated that allergen immunotherapy may prevent the development of asthma in people with allergic rhinitis. The present study aimed to assess the effect of subcutaneous immunotherapy with specific allergens on clinical symptoms, immunological factors, and cytokines in patients with allergic rhinitis and allergic asthma from the Kyrgyz Republic. This retrospective cohort study was conducted on patients with a slight to moderate level of persistent asthma and moderate to severe allergic rhinitis who had been referred to Osh State Clinic in Osh city, Kyrgyz Republic, from March 2000 to February 2025. About 160 atopic patients with allergic rhinitis and asthma were included in the study; confirmed by history, physical examination, and SPT, irrespective of gender. In patients with allergic asthma, 23 (58.97%) patients showed complete symptom improvement, 11 (28.2%) patients showed complete improvement, and 5 (12.82%) patients showed no response to treatment. Compared to previous treatment in the allergic rhinitis group, the cytokine TGFβ was significantly increased (p < 0.001), while the levels of IFN-γ (p = 0.047) and FOXP3 (p = 0.013) were also insignificantly decreased after immunotherapy. This study examined the impact of standard subcutaneous immunotherapy on patients with allergic respiratory diseases. The study also shows that immunotherapy stands as the most effective treatment for asthma and nasal allergies in patients who meet selection criteria, especially when medications do not work.

  • Open Access

    Development and Assessment of a Self-Nanoemulsifying Drug Delivery System Containing Bilastine: An Effective Strategy to Improve Dissolution

    by Ishraq Kadhim Abbas, Alaa Abdulelah Abdulqader, Ahmed Abbas Hussein, Saba Abdulhadi Jaber, Samer Shukur Mohammed

    Background: Innovative approaches, including self-nanoemulsifying drug delivery systems, have the potential to solve a variety of drug formulation challenges, such as solubility, stability, and bioavailability. The drug candidate in this research is the strong and extremely selective H1-antihistamine, bilastine, that belongs to BCS II with low solubility and high permeability. Objective: This research aims to formulate an oral self-nanoemulsion of bilastine to improve dissolution. Methods: A total of fifteen liquid self-nanoemulsion drug delivery systems (SNEDDS) formulas were developed using oleic acid, cremophor, and Transcutol as the appropriate oils, stabilizers, and co-stabilizers based on the solubility studies of bilastine in various oils, stabilizers, and co-stabilizers. We used pseudoternary phase diagrams to look at the behavior of the component phases and the area of the nanoemulsion. The physicochemical properties of the formulas, in addition to thermodynamic stability, droplet size, polydispersity index, zeta potential, self-emulsification time, drug content, and durability of the developed formulations, were assessed. Results: This study demonstrated that formula 5, with a 20% oleic acid, 27% cremophor, and 53% Transcutol composition, had lower globular size, acceptable drug content, better in-vitro drug release, and ex-vivo permeability characteristics than pure bilastine powder. Conclusions: The mentioned factors all point to the preparation of self-nanoemulsifying drug delivery systems as a potential means for improving the dissolution of poorly soluble drugs like bilastine.

  • Open Access

    Effects of Lycopene as Monotherapy or Combined with Clobetasol on Spleen Index and Inflammatory Markers in Mouse Model of Imiquimod-Induced Psoriasis

    by Samer Shukur Mohammed, Wael Waleed Mustafa

    Background: Lycopene has demonstrated favorable impacts on diverse health conditions, particularly those of an inflammatory nature. Objective: To evaluate the impact of topical application of lycopene on the spleens of mice with psoriasis induced by imiquimod (IMQ). Methods: The study employed a sample size of 48 mice, divided into six groups of eight mice each. The experimental protocol involved the application of IMQ to each of the five groups twice. The first application was administered for six days to induce psoriasis, followed by a second application for another six days while the tested medications were concurrently administered, with the exception of the first group, which served as the control group. Following the six-day induction phase, group 2 was treated exclusively with petrolatum jelly. On the other hand, groups 3-6 were subjected to different treatments, including clobetasol propionate, lycopene at concentrations of 0.125 mg/ml and 0.25 mg/ml, and a combination of 0.05% clobetasol and 0.25 mg/ml of lycopene. Each of the examined pharmaceutical substances was administered topically once daily for a duration of six days at the IMQ application site. Results: Lycopene at a concentration of 0.25 mg/ml resulted in a significant reduction in the spleen index and a restoration of the tissue levels of inflammatory mediators (TNF-α, IL-23, NF-κB, and IL-17) that were close to normal. Conclusion: The anti-inflammatory properties of lycopene can significantly aid in the normalization of spleens in patients who have developed psoriasis due to imiquimod.matory capabilities.


  • Open Access

    Evaluation Lycopene effect as a monotherapy and add on to Clobetasol on Spleen inflammatory biomarkers and spleen index in IMQ induced psoriasis like inflammation in mice

    by Samer Shukur Mohammed, Wael Waleed Mustafa

    Lycopene is a nutraceutical pigment present in red fruits and vegetables. many researches proved the positive impact of lycopene on many diseases throughout several years especially on inflammation conditions, cardiovascular illness, prostate cancer, and various dermatological disorders. Objective: two different concentrations of topical Lycopene as a monotherapy and as addition therapy to Clobetasol on a mouse induced Psoriasis previously by Imiquimod. Methods: six groups that contain 8 mice in each group, totally 48 mice were used . Imiquimod was administered to five groups (except first Group , which is controlled group) for six consecutive days to induce psoriasis and further six days during application of tested agents. Group 2 received Petrolatum gel only for 6 consecutive days following six-days Imiquimod induction phase. Groups 3-6 received different materials Clobetasol propionate, 0.125 mg/ml and 0.25 mg/ml of Lycopene, and a combination of 0.05% Clobetasol with 0.25 mg/ml Lycopene, all tested material were applied as an ointment once daily for six days concomitantly with Imiquimod. Results: Lycopene showed significant decrease on spleen index and was able to restore the level of spleen inflammatory mediators (TNF-α, IL-23, NF-KB and IL-17,) to nearly normal one after utilizing Lycopene 0.25 mg/ml and when had been added to Clobetasol. Conclusion: Lycopene shows significant spleen normalizing action against Imiquimod-induced psoriasis via its anti-inflammatory action.


  • Open Access

    Study the topical effect of six days use of different lycopene doses on imiquimod-induce psoriasis-like skin inflammation in Mice

    by Samer Shukur Mohammed, Haitham Mahmood Kadhim, Israa Mahdi Al-Sudani, Wael Waleed Musatafa

    Lycopene is a hydrocarbon phytochemical that is present in red vegetables and fruits, several studies reviewed the pharmacological properties of Lycopene across years ago and in different aspects including inflammation, cardiovascular disease, prostatic cancer and different dermatological complaints. Objective: we investigated the potential impact of two different doses of topical Lycopene and as add on therapy to Clobetasol on Psoriasis model that induced by Imiquimod in mice. Methods: This was accomplished by dividing 48 mice into six groups (8 mice per each group). All groups received Imiquimod for induction of Psoriasis (except Group I which is healthy group) across the experiment days. Group II (Induction group) received Petrolatum gel (Vaseline) for six days after 6 days induction period with Imiquimod. The rest groups III, IV,V,VI received Clobetasol propionate 0.05%, 0.125 mg/ml Lycopene, 0.25 mg/ml Lycopene and combination of 0.25 mg/ml Lycopene and 0.05% Clobetasol propionate ointments respectively once daily for six days after 6 days of induction period with Imiquimod.